{
  "bio": [
    "Pablo Legorreta is the founder of Royalty Pharma, the world's biggest acquirer of pharmaceutical royalty streams.",
    "Royalty Pharma, which conducted an IPO in 2020, has collected revenue slices of blockbuster drugs like Humira, Imbruvica, Lyrica, and Xtandi.",
    "A former investment banker at Lazard Fr'res, Legoretta started Royalty Pharma in New York as a private equity vehicle in 1996.",
    "In May 2025, Royalty Pharma acquired its external investment manager RP Management in a $1.1 billion deal. Legorreta owned 100% of RPM until 2024, when he gave just under half his stake to employees"
  ],
  "about": []
}